LACRISERT Drug Patent Profile
✉ Email this page to a colleague
When do Lacrisert patents expire, and when can generic versions of Lacrisert launch?
Lacrisert is a drug marketed by Bausch And Lomb Inc and is included in one NDA.
The generic ingredient in LACRISERT is hydroxypropyl cellulose. There are forty-one drug master file entries for this compound. Additional details are available on the hydroxypropyl cellulose profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LACRISERT?
- What are the global sales for LACRISERT?
- What is Average Wholesale Price for LACRISERT?
Summary for LACRISERT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 30 |
| Drug Prices: | Drug price information for LACRISERT |
| What excipients (inactive ingredients) are in LACRISERT? | LACRISERT excipients list |
| DailyMed Link: | LACRISERT at DailyMed |
Pharmacology for LACRISERT
| Drug Class | Demulcent |
| Mechanism of Action | Demulcent Activity |
US Patents and Regulatory Information for LACRISERT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | LACRISERT | hydroxypropyl cellulose | INSERT;OPHTHALMIC | 018771-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
